Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  2. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  3. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  4. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  5. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  6. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  7. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  8. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  9. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  10. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  11. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  12. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  13. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  14. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  15. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  16. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  17. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  18. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  19. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  20. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  21. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  22. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  23. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  24. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  25. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  26. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  27. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  28. Mair F, et al. 2022. Nature. 605:728. PubMed
  29. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  30. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  31. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  32. Campisi L, et al. 2022. Nature. 606:945. PubMed
  33. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  34. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  35. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  36. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  37. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  38. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  39. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  40. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  41. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  42. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  43. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  44. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  45. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  46. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  47. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  48. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  49. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  50. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  51. Sun W, et al. 2023. Nature. 614:309. PubMed
  52. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  53. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  54. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  55. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  56. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  57. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  58. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  59. Wang CQ, et al. 2023. Cells. 12: . PubMed
  60. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  61. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  62. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  63. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  64. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  65. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  66. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  67. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  68. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  69. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  70. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  71. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  72. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  73. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  74. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  75. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  76. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  77. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  78. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  79. Li S, et al. 2022. Nature. 610:373. PubMed
  80. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  81. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  82. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  83. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  84. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  85. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  86. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  87. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  88. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  89. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  90. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  91. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  92. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  93. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  94. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  95. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  96. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  97. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  98. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  99. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  100. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  101. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  102. Gao F, et al. 2023. Immunity. 56:864. PubMed
  103. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  104. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  105. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  106. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  107. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  108. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  109. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  110. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  111. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  112. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  113. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  114. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  115. Solier S, et al. 2023. Nature. 617:386. PubMed
  116. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  117. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  118. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  119. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  120. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  121. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  122. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  123. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  124. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  125. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  126. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  127. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  128. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  129. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  130. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  131. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  132. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  133. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  134. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  135. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  136. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  137. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  138. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  139. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  140. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  141. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  142. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  143. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  144. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  145. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  146. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  147. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  148. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  149. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  150. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  151. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  152. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  153. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  154. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  155. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  156. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  157. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  158. Jairaman A, et al. 2022. Elife. 11:. PubMed
  159. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  160. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  161. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  162. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  163. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  164. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  165. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  166. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  167. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  168. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  169. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  170. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  171. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  172. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  173. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  174. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  175. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  176. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  177. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  178. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  179. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  180. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  181. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  182. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  183. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  184. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  185. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  186. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  187. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  188. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  189. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  190. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  191. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  192. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  193. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  194. Ogbe A, et al. 2022. JCI Insight. . PubMed
  195. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  196. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  197. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  198. Woodruff MC, et al. 2022. Nature. :. PubMed
  199. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  200. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  201. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  202. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  203. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  204. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  205. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  206. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  207. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  208. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  209. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  210. Dogra P, et al. 2020. Cell. 749:180. PubMed
  211. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  212. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  213. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  214. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  215. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  216. Vijayakumar B, et al. 2022. Immunity. . PubMed
  217. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  218. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  219. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  220. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  221. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  222. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  223. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  224. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  225. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  226. Kumar V, et al. 2022. Cells. 11:. PubMed
  227. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  228. Kreutmair S, et al. 2021. Immunity. . PubMed
  229. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  230. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  231. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  232. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  233. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  234. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  235. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  236. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  237. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  238. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  239. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  240. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  241. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  242. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  243. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  244. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  245. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  246. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  247. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  248. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  249. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  250. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  251. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  252. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  253. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  254. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  255. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  256. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  257. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  258. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  259. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  260. Romine KA, et al. 2021. Cancer Discov. . PubMed
  261. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  262. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  263. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  264. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  265. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  266. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  267. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  268. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  269. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  270. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  271. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  272. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  273. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  274. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  275. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  276. Thijssen R, et al. 2022. Blood. :. PubMed
  277. Good Z, et al. 2022. Nat Med. :. PubMed
  278. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  279. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  280. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  281. Shi J, et al. 2014. Blood. 123:4015. PubMed
  282. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  283. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  284. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  285. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  286. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  287. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  288. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  289. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  290. Woodruff M, et al. 2020. medRxiv. . PubMed
  291. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  292. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  293. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  294. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  295. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  296. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  297. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  298. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  299. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  300. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  301. Burns JC, et al. 2020. eLife. 9:00. PubMed
  302. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  303. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  304. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  305. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  306. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  307. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  308. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  309. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  310. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  311. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  312. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  313. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  314. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  315. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  316. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  317. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  318. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  319. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  320. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  321. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  322. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  323. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  324. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  325. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  326. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  327. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  328. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  329. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  330. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  331. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  332. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  333. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  334. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  335. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  336. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  337. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  338. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  339. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  340. Wang J, et al. 2022. iScience. 25:103971. PubMed
  341. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  342. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  343. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  344. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  345. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  346. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  347. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  348. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  349. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  350. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  351. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  352. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  353. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  354. Feng W, et al. 2020. J Vis Exp. . PubMed
  355. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  356. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  357. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  358. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  359. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  360. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  361. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  362. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  363. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  364. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  365. Song M, et al. 2018. Nature. 562:423. PubMed
  366. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  367. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  368. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  369. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  370. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  371. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  372. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  373. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  374. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  375. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  376. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  377. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  378. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  379. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  380. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  381. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  382. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  383. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  384. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  385. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  386. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  387. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  388. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  389. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  390. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  391. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  392. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  393. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  394. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  395. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  396. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  397. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  398. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  399. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  400. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  401. Georg P, et al. 2022. Cell. 185:493. PubMed
  402. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  403. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  404. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  405. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  406. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  407. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  408. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  409. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  410. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  411. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  412. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  413. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  414. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  415. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  416. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  417. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  418. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  419. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  420. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  421. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  422. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  423. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  424. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  425. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  426. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  427. Lederer K, et al. 2022. Cell. . PubMed
  428. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  429. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  430. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  431. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  432. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  433. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  434. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  435. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  436. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  437. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  438. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  439. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  440. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  441. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  442. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  443. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  444. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  445. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  446. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  447. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  448. Adamo S, et al. 2022. Nature. 602:148. PubMed
  449. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  450. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  451. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  452. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  453. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  454. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  455. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  456. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  457. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  458. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  459. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  460. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  461. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  462. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  463. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  464. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  465. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  466. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  467. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  468. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  469. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  470. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  471. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  472. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  473. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  474. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  475. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  476. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  477. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  478. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  479. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  480. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  481. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  482. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  483. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  484. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  485. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  486. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  487. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  488. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  489. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  490. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  491. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  492. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  493. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  494. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  495. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  496. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  497. Chen C, et al. 2022. iScience. 25:103645. PubMed
  498. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  499. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  500. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  501. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  502. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  503. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  504. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  505. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  506. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  507. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  508. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  509. Wang EY, et al. 2021. Nature. 595:283. PubMed
  510. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  511. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  512. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  513. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  514. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  515. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  516. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  517. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  518. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  519. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  520. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  521. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  522. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  523. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  524. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  525. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  526. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  527. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  528. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  529. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account